Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients (Q43034694)
Jump to navigation
Jump to search
scientific article published on 24 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients |
scientific article published on 24 February 2011 |
Statements
1 reference
Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients (English)
1 reference
Linda Chang
1 reference
Alicja Wiercinska-Drapalo
1 reference
Andrzej Horban
1 reference
Catherine Stedman
1 reference
Edward J Gane
1 reference
Regine Rouzier
1 reference
Ying Zhang
1 reference
Pratibha Sampeur
1 reference
Isabel Nájera
1 reference
Patrick Smith
1 reference
Nancy S Shulman
1 reference
Jonathan Q Tran
1 reference
24 February 2011
1 reference
1 reference
Identifiers
1 reference